載入...
Application of orphan drug designation to cancer treatments (2008–2017): a comprehensive and comparative analysis of the USA and EU
OBJECTIVE: To determine differences in the characteristics of cancer drugs designated as orphan drugs by the Food and Drug Administration (FDA) and European Medicines Agency (EMA). DESIGN AND SETTING: Identification of all cancer drugs (initial or supplementary indication) with orphan status approve...
Na minha lista:
| 發表在: | BMJ Open |
|---|---|
| Main Authors: | , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
BMJ Publishing Group
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6797305/ https://ncbi.nlm.nih.gov/pubmed/31601584 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2018-028634 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|